Johnson & Johnson(JNJ)
Drug Manufacturers - General · New Brunswick, NJ
$267.08-2.04 (-0.76%)
Delayed quote: Sep 9, 2026, 4:00 PM EDT
Drug Manufacturers - General · New Brunswick, NJ
Delayed quote: Sep 9, 2026, 4:00 PM EDT
The latest quarterly A/P is $9.22 Billion with a QoQ Growth of -11.83%. Accounts Payable (A/P) represents money the company owes to suppliers and vendors for goods and services received but not yet paid for.
Reported quarterly accounts payable; no daily interpolation. Q2 FY2026 (2026-06-28): $9.22B.
$9.22B
$9.22 Billion
-11.83%
vs. $10.46B prior quarter
96
Quarters of data available
| Period | A/P | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q2 FY2026Period end 2026-06-28 | $9.22B | -11.83% | -2.55% |
| Q1 FY2026Period end 2026-03-29 | $10.46B | -12.77% | +9.59% |
| Q4 FY2025Period end 2025-12-28 | $11.99B | +24.58% | +16.29% |
| Q3 FY2025Period end 2025-09-28 | $9.63B | +1.70% | +7.49% |
| Q2 FY2025Period end 2025-06-29 | $9.46B | -0.85% | +6.96% |
| Q1 FY2025Period end 2025-03-30 | $9.54B | -7.43% | +16.77% |
| Q4 FY2024Period end 2024-12-29 | $10.31B | +15.16% | +7.05% |
| Q3 FY2024Period end 2024-09-29 | $8.95B | +1.20% | +7.17% |
| Q2 FY2024Period end 2024-06-30 | $8.85B | +8.25% | -15.27% |
| Q1 FY2024Period end 2024-03-31 | $8.17B | -15.14% | -17.51% |
| Q4 FY2023Period end 2023-12-31 | $9.63B | +15.28% | -2.60% |
| Q3 FY2023Period end 2023-10-01 | $8.36B | -19.99% | -17.71% |
| Q2 FY2023Period end 2023-07-02 | $10.44B | +5.39% | +6.94% |
| Q1 FY2023Period end 2023-04-02 | $9.91B | +0.20% | +6.45% |
| Q4 FY2022Period end 2022-12-31 | $9.89B | -2.60% | -10.55% |
| Q3 FY2022Period end 2022-10-02 | $10.15B | +3.97% | +13.30% |
| Q2 FY2022Period end 2022-07-03 | $9.77B | +4.90% | +12.19% |
| Q1 FY2022Period end 2022-04-03 | $9.31B | -15.79% | +9.48% |
| Q4 FY2021Period end 2021-12-31 | $11.05B | +23.37% | +16.31% |
| Q3 FY2021Period end 2021-10-03 | $8.96B | +2.95% | +27.21% |
| Q2 FY2021Period end 2021-07-04 | $8.70B | +2.36% | +28.66% |
| Q1 FY2021Period end 2021-04-04 | $8.50B | -10.54% | +14.73% |
| Q4 FY2020Period end 2020-12-31 | $9.51B | +34.94% | +11.25% |
| Q3 FY2020Period end 2020-09-27 | $7.04B | +4.12% | -5.97% |
| Q2 FY2020Period end 2020-06-28 | $6.76B | -8.72% | -2.13% |
| Q1 FY2020Period end 2020-03-29 | $7.41B | -13.26% | +7.05% |
| Q4 FY2019Period end 2019-12-31 | $8.54B | +14.06% | +13.36% |
| Q3 FY2019Period end 2019-09-29 | $7.49B | +8.38% | +7.01% |
| Q2 FY2019Period end 2019-06-30 | $6.91B | -0.16% | +6.08% |
| Q1 FY2019Period end 2019-03-31 | $6.92B | -8.15% | +7.45% |
| Q4 FY2018Period end 2018-12-31 | $7.54B | +7.67% | +3.11% |
| Q3 FY2018Period end 2018-09-30 | $7.00B | +7.43% | +9.55% |
| Q2 FY2018Period end 2018-07-01 | $6.52B | +1.13% | +6.21% |
| Q1 FY2018Period end 2018-04-01 | $6.44B | -11.86% | +5.94% |
| Q4 FY2017Period end 2017-12-31 | $7.31B | +14.40% | +5.67% |
| Q3 FY2017Period end 2017-10-01 | $6.39B | +4.16% | +7.02% |
| Q2 FY2017Period end 2017-07-02 | $6.13B | +0.87% | +1.22% |
| Q1 FY2017Period end 2017-04-02 | $6.08B | -12.08% | +1.96% |
| Q4 FY2016Period end 2016-12-31 | $6.92B | +15.86% | +3.75% |
| Q3 FY2016Period end 2016-10-02 | $5.97B | -1.48% | +33.10% |
| Q2 FY2016Period end 2016-07-03 | $6.06B | +1.61% | -1.29% |
| Q1 FY2016Period end 2016-04-03 | $5.96B | -10.54% | -11.22% |
| Q4 FY2015Period end 2015-12-31 | $6.67B | +48.64% | -12.64% |
| Q3 FY2015Period end 2015-09-27 | $4.49B | -26.94% | -32.06% |
| Q2 FY2015Period end 2015-06-28 | $6.14B | -8.62% | -0.86% |
| Q1 FY2015Period end 2015-03-29 | $6.72B | -11.97% | +9.91% |
| Q4 FY2014Period end 2014-12-31 | $7.63B | +15.60% | +21.82% |
| Q3 FY2014Period end 2014-09-28 | $6.60B | +6.62% | +9.05% |
| Q2 FY2014Period end 2014-06-29 | $6.19B | +1.31% | +8.90% |
| Q1 FY2014Period end 2014-03-30 | $6.11B | -2.44% | +13.79% |
| Q4 FY2013Period end 2013-12-31 | $6.27B | +3.48% | +7.46% |
| Q3 FY2013Period end 2013-09-29 | $6.05B | +6.47% | +13.30% |
| Q2 FY2013Period end 2013-06-30 | $5.69B | +5.86% | +10.53% |
| Q1 FY2013Period end 2013-03-31 | $5.37B | -7.87% | +5.64% |
| Q4 FY2012Period end 2012-12-31 | $5.83B | +9.11% | +1.85% |
| Q3 FY2012Period end 2012-09-30 | $5.34B | +3.87% | -6.74% |
| Q2 FY2012Period end 2012-07-01 | $5.14B | +1.18% | -9.56% |
| Q1 FY2012Period end 2012-04-01 | $5.08B | -11.18% | -10.81% |
| Q4 FY2011Period end 2011-12-31 | $5.72B | -0.09% | +1.81% |
| Q3 FY2011Period end 2011-10-02 | $5.73B | +0.72% | +4.62% |
| Q2 FY2011Period end 2011-07-03 | $5.69B | -0.21% | +16.79% |
| Q1 FY2011Period end 2011-04-03 | $5.70B | +1.39% | +11.22% |
| Q4 FY2010Period end 2010-12-31 | $5.62B | +2.67% | +1.48% |
| Q3 FY2010Period end 2010-10-03 | $5.48B | +12.44% | -14.68% |
| Q2 FY2010Period end 2010-07-04 | $4.87B | -4.97% | -16.48% |
| Q1 FY2010Period end 2010-04-04 | $5.13B | -7.49% | -19.84% |
| Q4 FY2009Period end 2009-12-31 | $5.54B | -13.68% | -26.15% |
| Q3 FY2009Period end 2009-09-27 | $6.42B | +10.07% | +0.55% |
| Q2 FY2009Period end 2009-06-28 | $5.83B | -8.80% | -11.94% |
| Q1 FY2009Period end 2009-03-29 | $6.39B | -14.77% | -14.59% |
| Q4 FY2008Period end 2008-12-31 | $7.50B | +17.53% | +8.60% |
| Q3 FY2008Period end 2008-09-28 | $6.38B | -3.61% | +7.06% |
| Q2 FY2008Period end 2008-06-29 | $6.62B | -11.54% | +21.34% |
| Q1 FY2008Period end 2008-03-30 | $7.49B | +8.37% | +32.68% |
| Q4 FY2007Period end 2007-12-31 | $6.91B | +15.86% | +21.40% |
| Q3 FY2007Period end 2007-09-30 | $5.96B | +9.25% | +50.43% |
| Q2 FY2007Period end 2007-07-01 | $5.46B | -3.28% | +33.48% |
| Q1 FY2007Period end 2007-04-01 | $5.64B | -0.84% | +43.26% |
| Q4 FY2006Period end 2006-12-31 | $5.69B | +43.57% | +31.89% |
| Q3 FY2006Period end 2006-10-01 | $3.96B | -3.06% | +7.60% |
| Q2 FY2006Period end 2006-07-02 | $4.09B | +3.81% | +3.55% |
| Q1 FY2006Period end 2006-04-02 | $3.94B | -8.71% | -2.45% |
| Q4 FY2005Period end 2005-12-31 | $4.32B | +17.13% | -17.45% |
| Q3 FY2005Period end 2005-10-02 | $3.68B | -6.71% | +1.04% |
| Q2 FY2005Period end 2005-07-03 | $3.95B | -2.20% | +3.13% |
| Q1 FY2005Period end 2005-04-03 | $4.04B | -22.75% | +6.77% |
| Q4 FY2004Period end 2004-12-31 | $5.23B | +43.36% | +5.26% |
| Q3 FY2004Period end 2004-09-26 | $3.65B | -4.78% | -0.38% |
| Q2 FY2004Period end 2004-06-27 | $3.83B | +1.24% | +6.69% |
| Q1 FY2004Period end 2004-03-28 | $3.78B | -23.84% | +22.91% |
| Q4 FY2003Period end 2003-12-31 | $4.97B | +35.68% | +37.14% |
| Q3 FY2003Period end 2003-09-28 | $3.66B | +1.98% | +46.22% |
| Q2 FY2003Period end 2003-06-29 | $3.59B | +16.64% | N/A |
| Q1 FY2003Period end 2003-03-30 | $3.08B | -15.02% | N/A |
| Q4 FY2002Period end 2002-12-31 | $3.62B | +44.67% | N/A |
| Q3 FY2002Period end 2002-09-29 | $2.50B | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.